Stock Quotes & Company News | Reuters.com
Edition:
United States

People: Transition Therapeutics Inc (TTH.TO)

TTH.TO on Toronto Stock Exchange

0.98CAD
21 Jun 2016
Change (% chg)

-- (--)
Prev Close
$0.98
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,682
52-wk High
$3.87
52-wk Low
$0.94

Connop, Bruce 

Dr. Bruce Connop is Vice President - Non-Clinical & Pharmaceutical Development of Transition Therapeutics Inc. Dr. Connop has been with Transition since 2006 and served as Sr. Director, Nonclinical Drug Development until he was appointed VP, Non-Clinical & Pharmaceutical Development in 2012. With his expertise in pharmacology, toxicology and manufacturing he is responsible for a broad range of activities and has made significant contributions to the advancement of pipeline products. Dr. Connop holds a Ph.D. from Queen’s University and has had experience at other biotech and pharmaceutical companies.

Basic Compensation

Total Annual Compensation, CAD 194,782
Restricted Stock Awards, CAD --
Long-Term Incentive Plans, CAD --
All Other, CAD 92,400
Fiscal Year Total, CAD 287,182

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Cruz

424,876

Carl Damiani

199,228

Nicole Rusaw

316,054

Bruce Connop

287,182

Aleksandra Pastrak

407,711

Louis Alexopoulos

--
As Of  29 Jun 2013